TRPV1 and Fever: FT-A alleviated fever of yeast-induced pyrexia mice via suppression of TRPV1 expression and activation, inhibition of MAPKs, activation of the hypothalamus and DRG, and subsequently decreased secretion of pyretic cytokine as PGE2 and IL-8 (Liu et al., 2017).In addition, FT-A can significantly enhance the phagocytic function of macrophages in LPS-stimulated ra-w264.7 cells and reduce the secretion of TNF-α (Guan et al., 2013).